Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes

The aim of this study is to investigate the circulating OPG levels in postmenopausal women with diabetes and prediabetes and explore the relationships between serum OPG and insulin resistance. A total of 271 unrelated Chinese postmenopausal women were recruited in this study. The subjects were divid...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng Duan, Min Yang, Meilin Wei, Jia Liu, Ping Tu
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2017/8724869
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551639333994496
author Peng Duan
Min Yang
Meilin Wei
Jia Liu
Ping Tu
author_facet Peng Duan
Min Yang
Meilin Wei
Jia Liu
Ping Tu
author_sort Peng Duan
collection DOAJ
description The aim of this study is to investigate the circulating OPG levels in postmenopausal women with diabetes and prediabetes and explore the relationships between serum OPG and insulin resistance. A total of 271 unrelated Chinese postmenopausal women were recruited in this study. The subjects were divided into type 2 diabetes mellitus (T2DM) group (n=93), impaired glucose regulation (IGR) (n=90), and normal glucose regulation group (NGR) (n=88), according to different glucose regulation categories. Serum OPG levels were measured by enzyme-linked immunosorbent assay. The serum OPG concentration in NGR group, 151.00 ± 45.72 pg/mL, was significantly lower than that in IGR group (169.28 ± 64.91 pg/mL) (p=0.031) and T2DM group (183.20 ± 56.53 pg/mL) (p<0.01), respectively. In multiple linear regression analysis, HOMA-IR, age, 2hPG, AST, ALP, and eGFR were found to be independent predictors of OPG. Increased serum OPG levels (OR = 1.009, p=0.006) may be a risk factor for insulin resistance. The present study suggests that OPG might be implicated in the pathogenesis of diabetes and is a potential biomarker of insulin resistance in subjects with diabetes and prediabetes.
format Article
id doaj-art-de9a226969374081aeefac3033a4d0ab
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-de9a226969374081aeefac3033a4d0ab2025-02-03T06:01:06ZengWileyInternational Journal of Endocrinology1687-83371687-83452017-01-01201710.1155/2017/87248698724869Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 DiabetesPeng Duan0Min Yang1Meilin Wei2Jia Liu3Ping Tu4Department of Endocrinology and Metabolism, Nanchang Key Laboratory of Diabetes, The Third Hospital of Nanchang, No. 2 Xiangshan South Road, Nanchang, Jiangxi 330009, ChinaDepartment of Finance, Nanchang Normal University, No. 889 Ruixiang Road, Nanchang, Jiangxi 330009, ChinaDepartment of Endocrinology and Metabolism, Nanchang Key Laboratory of Diabetes, The Third Hospital of Nanchang, No. 2 Xiangshan South Road, Nanchang, Jiangxi 330009, ChinaDepartment of Endocrinology and Metabolism, Nanchang Key Laboratory of Diabetes, The Third Hospital of Nanchang, No. 2 Xiangshan South Road, Nanchang, Jiangxi 330009, ChinaDepartment of Endocrinology and Metabolism, Nanchang Key Laboratory of Diabetes, The Third Hospital of Nanchang, No. 2 Xiangshan South Road, Nanchang, Jiangxi 330009, ChinaThe aim of this study is to investigate the circulating OPG levels in postmenopausal women with diabetes and prediabetes and explore the relationships between serum OPG and insulin resistance. A total of 271 unrelated Chinese postmenopausal women were recruited in this study. The subjects were divided into type 2 diabetes mellitus (T2DM) group (n=93), impaired glucose regulation (IGR) (n=90), and normal glucose regulation group (NGR) (n=88), according to different glucose regulation categories. Serum OPG levels were measured by enzyme-linked immunosorbent assay. The serum OPG concentration in NGR group, 151.00 ± 45.72 pg/mL, was significantly lower than that in IGR group (169.28 ± 64.91 pg/mL) (p=0.031) and T2DM group (183.20 ± 56.53 pg/mL) (p<0.01), respectively. In multiple linear regression analysis, HOMA-IR, age, 2hPG, AST, ALP, and eGFR were found to be independent predictors of OPG. Increased serum OPG levels (OR = 1.009, p=0.006) may be a risk factor for insulin resistance. The present study suggests that OPG might be implicated in the pathogenesis of diabetes and is a potential biomarker of insulin resistance in subjects with diabetes and prediabetes.http://dx.doi.org/10.1155/2017/8724869
spellingShingle Peng Duan
Min Yang
Meilin Wei
Jia Liu
Ping Tu
Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes
International Journal of Endocrinology
title Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes
title_full Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes
title_fullStr Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes
title_full_unstemmed Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes
title_short Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes
title_sort serum osteoprotegerin is a potential biomarker of insulin resistance in chinese postmenopausal women with prediabetes and type 2 diabetes
url http://dx.doi.org/10.1155/2017/8724869
work_keys_str_mv AT pengduan serumosteoprotegerinisapotentialbiomarkerofinsulinresistanceinchinesepostmenopausalwomenwithprediabetesandtype2diabetes
AT minyang serumosteoprotegerinisapotentialbiomarkerofinsulinresistanceinchinesepostmenopausalwomenwithprediabetesandtype2diabetes
AT meilinwei serumosteoprotegerinisapotentialbiomarkerofinsulinresistanceinchinesepostmenopausalwomenwithprediabetesandtype2diabetes
AT jialiu serumosteoprotegerinisapotentialbiomarkerofinsulinresistanceinchinesepostmenopausalwomenwithprediabetesandtype2diabetes
AT pingtu serumosteoprotegerinisapotentialbiomarkerofinsulinresistanceinchinesepostmenopausalwomenwithprediabetesandtype2diabetes